Assessing Pre-Existing Antibodies (PEXA) in Biotherapeutic Development

A patient may have pre-existing antibodies (PEXA) to a therapeutic, which can impact the immune response to the drug in question. In this paper, we discuss the nature of PEXAs, how they can be detected and characterized, and how sponsors should proceed when they are present.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Company*

State*